NCT06618755 Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
| NCT ID | NCT06618755 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Montpellier |
| Condition | Alcohol Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 104 participants |
| Start Date | 2024-12-18 |
| Primary Completion | 2028-01-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 104 participants in total. It began in 2024-12-18 with a primary completion date of 2028-01-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this clinical study is to evaluate the efficacy of reinforced inpatient aftercare versus usual care on the percentage of days of abstinence during the first year following withdrawal in adults with alcohol use disorders undergoing inpatient withdrawal. The hypothesis is that reinforced post-withdrawal follow-up, of the motivational interview type, during the first 4 months following hospitalisation, in addition to the usual care, would allow : * Increase the percentage of days of abstinence in the year following withdrawal. * Reduce the rate of relapse in the year following withdrawal. * An increase in the cumulative and maximum duration of abstinence, an increase in motivation to maintain the change initiated and a reduction in the use of other substances in the year following withdrawal. * A reduction in the impact of risk factors involved in the relapse process in the year following withdrawal. All participants will have assessments to monitor their abstinence and consumption. In addition to their assessments, the experimental group will have motivational talks once every 15 days.
Eligibility Criteria
Inclusion Criteria: * With alcohol use disorders defined by at least 2 DSM-V criteria for at least 12 months). * Being treated for withdrawal in hospital. * With a goal of complete abstinence. * With a means of communication (telephone). Exclusion Criteria: * Lack of understanding (written and spoken) of the French language. * Breach of HC withdrawal contract, following failure to comply with the rules of the addictology service and somatic complications of addiction. * Eviction from the department, discharge against medical advice during hospitalisation for withdrawal. * Proven cognitive problems compromising understanding of the implications of the study and the proposed follow-up. proposed follow-up. * Serious decompensated somatic pathology. * Non-membership or non-beneficiaries of a national health insurance scheme. * Person protected by law, under guardianship or curatorship. * Not having signed free and informed consent to participate in the research. * Simultaneous participation in another clinical trial.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06618755 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alcohol Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06618755 currently recruiting?
Yes, NCT06618755 is actively recruiting participants. Contact the research team at t-risdorferdeissdentzi@chu-montpellier.fr for enrollment information.
Where is the NCT06618755 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT06618755 clinical trial?
NCT06618755 is sponsored by University Hospital, Montpellier. The trial plans to enroll 104 participants.